Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127818) titled 'Construction of an evaluation system for the cardiac safety of anti - tumor drugs based on multi - modal data models' on July 8.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Harbin Medical University Cancer Hospital
Condition:
Malignant solid tumors (lung cancer, breast cancer, gastrointestinal cancer, ovarian cancer, etc.), antineoplastic drug-related cardiotoxicity (myocardial injury, cardiac dysfunction, arrhythmia, heart failure, etc.)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-08
Target Sample Size: Antineoplastic drug treatment gr...